SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.05-0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (13778)1/26/1998 3:50:00 PM
From: Flagrante Delictu  Read Replies (1) of 32384
 
Andy, Thanks for the tip on downloading Adobe Acrobat & viewing the update. I used the url provided by Howard S., so my thanks are also due to him. Lehman indicated LGND didn't lose much from PFE's cancellation of the phase 3 trials in metastatic breast cancer & encouragingly pointed out that PFE would now have more resources to expend on their trial of Droloxifene for the much larger indication of osteoporosis. In addition PFE mentioned they would try the compound in the prevention of breast cancer as well as other women's health issues. We were unaware of these possibilities previously & can now take some succor {iywpte} from them. Bernie {iywpte} = if you will pardon the expression.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext